Last Update 30 07 2017
NEWS
  • 21.10.2016
    FDA Approves Merck’s Zinplava (bezlotoxumab) to Reduce Recurrence of Clostridium difficile Infection

  • 20.10.2016
    FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma -

  • 19.01.2017
    FDA Approves Trulance (plecanatide) for Chronic Idiopathic Constipation

  • 31.01.2017
    Teva Announces FDA Approval of ArmonAir RespiClick (fluticasone propionate) for Maintenance Treatment of Asthma

  • 30.01.2017
    Teva Announces FDA Approval of AirDuo RespiClick (fluticasone propionate and salmeterol) for Maintenance Treatment of Asthma

  • 08.02.2017
    FDA Approves Amgen's Parsabiv (etelcalcetide) for Secondary Hyperparathyroidism in Adult Patients on Hemodialysis

  • 09.02.2017
    FDA Approves Emflaza (deflazacort) to treat Duchenne Muscular Dystrophy


Equivamed is the ultimate solution to find equivalent drugs in multiple countries It can be used by Pharmacist as well as Doctor, Veterinary or even non professional people.
Our wish is to help people anywhere in the world to to find treatment matching their pathology. Equivamed is a user Friendly web application reachable from any browser.
Its repository is referencing More than 1.700 000 Drugs More than 9500 DCI More than 220 countries worldwide , EquivaMed is daily updated Each entry is double checked before it’s integration to our system by experimented pharmacists.
Take a free test by clicking this link


NEW PRODUCTS
  • new product 香砂养胃丸
  • new product 十全大补丸
  • new product 杞菊地黄丸
  • new product エイムゲン
  • new product アブラキサン点滴静注用100mg
  • new product インデラル錠10mg、インデラル錠20mg
  • new product YERVOY (ipilimumab)
  • new product וימפט 50 מ"ג
  • new product פרג'טה
  • new product סיברי בריזהלר 50 מק"ג
  • new product אריוודג'
  • new product בייאטה 10 מק"ג
  • new product בייאטה 5 מק"ג
  • new product קפרלסה 100 מ"ג
  • new product Hetlioz (tasimelteon)
  • new product Vimizim (elosufase alfa)
  • new product Myalept (metreleptin)
  • new product Tivorbex (indomethacin)
  • new product Northera (droxidopa)
  • new product Otezla (apremilast)
  • new product Alprolix (coagulation factor IX (recombinant))
  • new product Evzio (naloxone hydrochloride)
  • new product Cyramza (ramucirumab)
  • new product Sylvant (siltuximab)
  • new product Zykadia (ceritinib)
  • new product Zontivity (vorapaxar)
  • new product Entyvio (vedolizumab)
  • new product Dalvance (dalbavancin)
  • new product Omidria (ketorolac and phenylephrine)
  • new product Jublia (efinaconazole)
  • new product Sivextro (tedizolid)
  • new product Beleodaq (belinostat)
  • new product Kerydin (tavaborole)
  • new product Zydelig (idelalisib)
  • new product Striverdi Respimat (olodaterol)
  • new product Belsomra (suvorexant)
  • new product Triumeq (abacavir, dolutegravir and lamivudine)
  • new product Keytruda (pembrolizumab)
  • new product Trulicity (dulaglutide)
  • new product Iluvien (fluocinolone acetonide)
  • new product Vitekta (elvitegravir)
  • new product Tybost (cobicistat)
  • new product Harvoni (ledipasvir and sofosbuvir)
  • new product Akynzeo (netupitant and palonosetron)
  • new product Lumason (sulfur hexafluoride lipid microsphere)
  • new product Blincyto (blinatumomab)
  • new product Xtoro (finafloxacin)
  • new product Zerbaxa (ceftolozane and tazobactam)
  • new product Viekira Pak (ombitasvir/paritaprevir/ritonavir with dasabuvir)
  • new product Lynparza (olaparib)
  • new product Natpara (recombinant human parathyroid hormone)
  • new product Evotaz (atazanavir and cobicistat)
  • new product Prezcobix (cobicistat and darunavir)
  • new product Glyxambi (empagliflozin and linagliptin)
  • new product Pazeo (olopatadine hydrochloride)
  • new product Ibrance (palbociclib)
  • new product Farydak (panobinostat)
  • new product Avycaz (avibactam and ceftazidime)
  • new product Cresemba (isavuconazonium)
  • new product Unituxin (dinutuximab)
  • new product Orkambi (ivacaftor and lumacaftor)
  • new product Entresto (sacubitril and valsartan)
  • new product Rexulti (brexpiprazole)
  • new product Technivie (ombitasvir, paritaprevir and ritonavir)
  • new product Odomzo (sonidegib)
  • new product Daklinza (daclatasvir)
  • new product Praluent (alirocumab)
  • new product Repatha (evolocumab)
  • new product Varubi (rolapitant)
  • new product Xuriden (uridine triacetate)
  • new product Vraylar (cariprazine)
  • new product Imlygic (talimogene laherparepvec)
  • new product Nuplazid (pimavanserin)
  • new product Tecentriq (atezolizumab)
  • new product Axumin (fluciclovine F 18)